FDA Awards Lipogems Second IDE Study for Knee OA
The IDE Study will be conducted for the safety and efficacy for the treatment of knee osteoarthritis compared to saline....
The IDE Study will be conducted for the safety and efficacy for the treatment of knee osteoarthritis compared to saline....
NovaBone Products has launched a first foot and ankle-specific syringe delivery system for its bioactive glass....
The FDA 510(k) clearance allows surgeons to use OssDsign Catalyst on-label in any interbody cage cleared for use with synthetic...
OssDsign Catalyst is a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion....
The PROPEL registry was initiated in March 2022 to gather real-world data from patients who have been treated with OssDsign...
CartiHeal announced the first commercial implantation of Agili-C in the U.S. The Agili-C implant features a bi-phasic design that supports both...
The engineered allogenic osteochondral graft has shown promise in preclinical studies and could benefit people with damaged knee cartilage caused...
The recall relates to bone repair products made from human tissue that are used primarily in orthopedic and spinal procedures....
Kuros completed enrollment in the STRUCTURE trial, investigating Fibrin-PTH (KUR-113) in single-level transforaminal lumbar interbody fusion....
Improvements to CERAMENT G antibiotic-eluting bone graft substitute have been made to increase ease of use and reduce environmental impact....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.